EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular Study of the Fukutin-Related Protein (FKRP) Gene in Patients from Southern Italy with Duchenne/Becker-like Phenotype

Antonio Qualtieri, Selene De Benedittis iD, Annamaria Cerantonio, Luigi Citrigno iD, Gemma Di Palma, Olivier Gallo, Francesca Cavalcanti iD, Patrizia Spadafora iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms251910356 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Antonio Qualtieri und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Biomedical Research and Innovation, National Research Council, 87050 Mangone, Italy. Hauptthemen laut MEDLINE: Phenotype, Muscular Dystrophy, Duchenne, Pentosyltransferases, Mutation. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pathogenic variants localized in the gene coding for the Fukutin-Related Protein (FKRP) are responsible for Limb-Girdle Muscular Dystrophy type 9 (LGMDR9), Congenital Muscular Dystrophies type 1C (MDC1C), Walker–Warburg Syndrome (WWS), and Muscle–Eye–Brain diseases (MEBs). LGMDR9 is the fourth most common hereditary Limb Girdle Muscular Dystrophy in Italy. LGMDR9 patients with severe disease show an overlapping Duchenne/Becker phenotype and may have secondary dystrophin reduction on muscle biopsy. We conducted a molecular analysis of the FKRP gene by direct sequencing in 153 patients from Southern Italy (Calabria) with Duchenne/Becker-like phenotypes without confirmed genetic diagnosis. Mutational screening of the patients (112 men and 41 women, aged between 5 and 84 years), revealed pathogenic variants in 16 subjects. The most frequent variants identified were c.427C > A, p.R143S, and c.826C > A, p.L276I (NM_024301.5). The results obtained show that the Duchenne/Becker-like phenotype is frequently determined by mutations in the FKRP gene in our cohort and highlight the importance of considering LGMDR9 in the differential diagnosis of dystrophinopathies in Calabria. Finally, this study, which, to our knowledge, is the first conducted on Calabrian subjects, will contribute to the rapid identification and management of LGMDR9 patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhenotypeMuscular Dystrophy, DuchennePentosyltransferasesMutationHumansMaleFemaleItalyChildAdolescentAdultChild, PreschoolMiddle AgedAgedYoung AdultAged, 80 and overProteins

Stichwörter der Autor:innen

FKRPLGMD2ILGMDR9limb girdle muscular dystrophy type R9molecular dynamic

Substanzen

FKRP protein, humanPentosyltransferasesProteins

Autor:innen und Institutionen

  • Institute for Biomedical Research and Innovation, National Research Council, 87050 Mangone, Italy.

ORCID-Profile: Selene De Benedittis, Luigi Citrigno, Francesca Cavalcanti, Patrizia Spadafora

Zitieren

APA

Qualtieri, A., De Benedittis, S., Cerantonio, A., Citrigno, L., Di Palma, G., Gallo, O., Cavalcanti, F., & Spadafora, P. (2024). Molecular Study of the Fukutin-Related Protein (FKRP) Gene in Patients from Southern Italy with Duchenne/Becker-like Phenotype. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251910356

Vancouver

Qualtieri A, De Benedittis S, Cerantonio A, Citrigno L, Di Palma G, Gallo O, et al. Molecular Study of the Fukutin-Related Protein (FKRP) Gene in Patients from Southern Italy with Duchenne/Becker-like Phenotype. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251910356

BibTeX
@article{Qualtieri2024,
  author = {Qualtieri, Antonio and De Benedittis, Selene and Cerantonio, Annamaria and Citrigno, Luigi and Di Palma, Gemma and Gallo, Olivier and Cavalcanti, Francesca and Spadafora, Patrizia},
  title = {Molecular Study of the Fukutin-Related Protein (FKRP) Gene in Patients from Southern Italy with Duchenne/Becker-like Phenotype},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms251910356}
}
Kostenlos starten →